BacterioScan, Inc.
Biotechnology company · St. Louis, Missouri, United States
BacterioScan, Inc. is a biotechnology company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2010. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $210,937 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $5.7 million sold in a notice filed in 2015.
BacterioScan at a glance
What does BacterioScan do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $210,937 in total (2018). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $5.7 million sold (2015).
Frequently asked questions about BacterioScan
Where is BacterioScan headquartered?
BacterioScan, Inc. is headquartered in St. Louis, Missouri, United States.
What does BacterioScan do?
BacterioScan, Inc. is a biotechnology company.
When was BacterioScan founded?
The earliest incorporation on record for BacterioScan, Inc. is in 2010, according to public company registers.
Similar companies
- MediBeacon Inc.St. Louis, Missouri, United States
- C2N Diagnostics, LLCSt. Louis, Missouri, United States
- Pulse Therapeutics, Inc.St. Louis, Missouri, United States
- Panome Bio Inc.St. Louis, Missouri, United States
- Cardialen, Inc.St. Louis, Missouri, United States
- Gateway Biotechnology, Inc.St. Louis, Missouri, United States
- Confluence Life Sciences, Inc.St. Louis, Missouri, United States
- Precision Virologics, Inc.St. Louis, Missouri, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences